- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03641261
Therapeutic Education Using an Internet Application in Hereditary Ichthyosis (e-ETPichtyose)
April 11, 2024 updated by: University Hospital, Toulouse
Evaluation of the Feasibility and Effect of Therapeutic Education Sessions Using an Internet Application in Hereditary Ichthyosis
The main purpose is to evaluate the feasibility (global use) of a therapeutic patient education program using a specific web application in patients with hereditary ichthyosis.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
42
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Juliette Mazereeuw-Hautier, MD
- Phone Number: +33 05 61 77 81 41
- Email: mazereeuw-hautier.j@chu-toulouse.fr
Study Contact Backup
- Name: Isabelle Dreyfus, PharmD
- Phone Number: +33 05 67 77 81 10
- Email: dreyfus.i@chu-toulouse.fr
Study Locations
-
-
-
Toulouse, France, 31059
- CHU Toulouse, Hôpital Larrey
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years to 60 years (Child, Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patient with hereditary ichthyosis, according to the classification established during the 2009 consensus conference
- Who has given his informed consent form
- Who is affiliated to a social security system
Exclusion Criteria:
- Patient who has already participated in a therapeutic patient education program for the hereditary ichthyosis
- Unable to connect or use a computer tool
- Impossibility to be present at the only face-to-face session
- Patient who is not available for the collective educational session
- Patient with little or no motivation to follow a therapeutic patient education program (motivation evaluated by the educational team by phone call before inclusion)
- Patient not mastering the French language
- Person under legal protection (guardianship, curators or safeguard of justice)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Therapeutic Patient Education program
All included patients will follow a Therapeutic Patient Education program dedicated to the hereditary ichthyosis and using a web application, WebIchtyose
|
WebIchtyose is a specific therapeutic patient education program for patients with hereditary Ichthyosis targeting the problems of each patient by means of a personalized follow-up and a constant interaction between the patient and the educational team
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Global use
Time Frame: 6 months
|
percentage of patients who have used the "WebIchtyose" application for at least 8 hours during 6 months
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fractional use in each domain (educational sessions)
Time Frame: 6 months
|
"WebIchtyose" application use time by the patient for group and individual educational sessions
|
6 months
|
Fractional use in each domain (continuous educational follow-up)
Time Frame: 6 months
|
"WebIchtyose" application use time by the patient for the continuous educational follow-up
|
6 months
|
Fractional use in each domain (consultation)
Time Frame: 6 months
|
"WebIchtyose" application use time by the patient for the consultation of the "Frequently Asked Questions" area and of patient information documents made available on the application
|
6 months
|
Fractional use in each domain (questionnaires)
Time Frame: 6 months
|
"WebIchtyose" application use time by the patient for the filling of the questionnaires
|
6 months
|
Fractional use in each domain
Time Frame: 6 months
|
"WebIchtyose" application use time by the patient for group and individual educational sessions, the continuous educational follow-up, the consultation of the "Frequently Asked Questions" area and of patient information documents made available on the application
|
6 months
|
Difficulty of individual application registration
Time Frame: Baseline
|
Difficulty of registration questionnaire completed for each patient jointly by the patient and the educational team at the end of the face-to-face inclusion visit
|
Baseline
|
Difficulties of use in everyday life by the patient
Time Frame: 6 months
|
Questionnaire completed for each patient jointly by the patient at the end of the program
|
6 months
|
Number of exchanges
Time Frame: 3 months and 5 months
|
Number of exchanges necessary between the educational team and the patient to set a date for the conduct of the individual educational sessions
|
3 months and 5 months
|
Response time
Time Frame: 6 months
|
Response time of the educational team following a request from the patient as part of the educational follow-up
|
6 months
|
Number of relaunches
Time Frame: 2 months, 4 months and 6 months
|
How many times the nurse relaunches the patient to obtain the assessment questionnaires
|
2 months, 4 months and 6 months
|
Number of non-received questionnaires
Time Frame: 2 months, 4 months and 6 months
|
Number of non-received questionnaires after relaunch
|
2 months, 4 months and 6 months
|
Number of lost to follow-up patients
Time Frame: 9 months
|
Number of lost to follow-up patients
|
9 months
|
Patient acceptability
Time Frame: 6 months
|
Acceptability questionnaire to be completed by the patient
|
6 months
|
Educational team acceptability
Time Frame: 6 months
|
Acceptability questionnaire to be completed by each member of the educational team
|
6 months
|
Attractiveness
Time Frame: 6 months
|
Application attractiveness questionnaire completed by the patient
|
6 months
|
Quality of life before and after treatment
Time Frame: Inclusion, 6 months and 9 months
|
Quality of life questionnaire for hereditary ichthyosis (IQoL-32)
|
Inclusion, 6 months and 9 months
|
Self-assessment of cutaneous severity
Time Frame: Inclusion and 6 months
|
Self-assessment of cutaneous severity according to an analogic visual scale for pain, pruritus, erythema, squama
|
Inclusion and 6 months
|
Knowledge about disease and treatments
Time Frame: Inclusion and 6 months
|
Questionnaire of knowledge about disease and treatments
|
Inclusion and 6 months
|
Self-care skills
Time Frame: Inclusion and 6 months
|
Questionnaire of self-care skills
|
Inclusion and 6 months
|
Self-esteem
Time Frame: Inclusion and 6 months
|
Questionnaire about self-esteem: Rosenberg scale.
For each item of the questionnaire, the modality answers are : 1 (totally disagree), 2 (quite disagree), 3 (quite agree) and 4 (totally disagree).
The total score (/ 40) is calculated by adding the scores obtained for each item.
|
Inclusion and 6 months
|
Coping scale
Time Frame: Inclusion and 6 months
|
Coping with health injuries and problem (Endler 1998).
For each item of the questionnaire, the modality answers are: 1 (not at all), 2 (a little), 3 (moderately), 4 (often) and 5 (a lot).The total score (/ 160) is calculated by adding the scores obtained for each item.
|
Inclusion and 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Juliette Mazereeuw-Hautier, MD, University Hospital, Toulouse
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 29, 2018
Primary Completion (Actual)
February 21, 2023
Study Completion (Actual)
February 21, 2023
Study Registration Dates
First Submitted
June 4, 2018
First Submitted That Met QC Criteria
August 17, 2018
First Posted (Actual)
August 21, 2018
Study Record Updates
Last Update Posted (Actual)
April 12, 2024
Last Update Submitted That Met QC Criteria
April 11, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RC31/16/8765
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ichthyosis
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingAutosomal Recessive Congenital Ichthyosis | Epidermolytic IchthyosisFrance
-
Centre Hospitalier Universitaire de NiceUnknownLamellar IchthyosisFrance
-
Krystal Biotech, Inc.Not yet recruitingAutosomal Recessive IchthyosisUnited States
-
Krystal Biotech, Inc.Active, not recruitingTGM-1 Related Autosomal Recessive Congenital IchthyosisUnited States
-
Northwestern UniversityIcahn School of Medicine at Mount SinaiCompletedNetherton Syndrome | Ichthyosis | Lamellar Ichthyosis | Autosomal Recessive Congenital Ichthyosis | Congenital Ichthyosiform Erythroderma | Epidermolytic IchthyosisUnited States
-
Maastricht University Medical CenterRecruiting
-
Crown Laboratories, Inc.CompletedIchthyosis VulgarisUnited States
-
Yale UniversityFoundation for Ichthyosis & Related Skin Types (FIRST)TerminatedIchthyosisUnited States
-
Patagonia Pharmaceuticals, LLCCompletedCongenital IchthyosisUnited States
-
National Medical Research Center for Children's...RecruitingCongenital IchthyosisRussian Federation
Clinical Trials on Therapeutic patient education program
-
Ain Shams UniversityActive, not recruiting
-
Ayşe ARIKAN DÖNMEZNot yet recruitingDementia | Virtual Reality | Education | Nursing StudentsTurkey
-
University Hospital, GrenobleMedico-economic evaluation unit , University Hospital, GrenobleCompleted
-
University Hospital, ToulouseActive, not recruiting
-
University Hospital, CaenUniversity of Lille Nord de France; CERFEP CARSAT Nord-Picardie; INSERM U1086...UnknownHead and Neck CancerFrance
-
JOSE MIGUEL MORALES ASENCIOUnknownDiabetes Mellitus, Type 2Spain
-
Institut de Cancérologie de la LoireCompleted
-
Institut de Cancérologie de la LoireCentre Leon Berard; Hospices Civils de LyonUnknown
-
University Hospital, ToulouseCompleted
-
Assistance Publique Hopitaux De MarseilleUnknownType 1 Pediatric DiabetesFrance